|
1. Drug inspectors warn of slower checks following FDA layoffs Full story
2. Common drug may limit cancer treatment's efficacy: Study Full story
3. From backlog to throughput: How MultiCare added surgical cases with existing resources — here.
4. FDA OKs rare disease drug weeks after missed decision deadline Full story
5. 48 health systems with strong finances Full story
6. Your EHR doesn't know everything. Find out what it's missing here.
7. 1st malaria drug for infants approved Full story
8. Trump's new tariffs: 4 things to know Full story
9. Medicaid cuts will cause 16,500+ deaths annually: Study Full story
10. CMS under Dr. Oz: 12 key actions Full story
11. Health insurers stumble: 5 things to know Full story
12. Delaying AI strategy? Why that's risky for health systems — insights from leaders here.
Becker's Learning Opportunities
13. See how cancer centers are expanding without hiring here.
14. Questions still linger about the safety of hospital-at-home models. What clinical leaders should know: here.
15. New study: 1% of AI clinical answers posed risk. Full findings here
|
